Big Pharma hits back at watchdog
NCPE expert said 95 per cent of new cancer drugs were bad value
The pharmaceutical sector has attacked claims by the medicines watchdog that expensive cancer drugs are not delivering.
In a letter sent to TDs and senators last week, the Irish Pharmaceutical Healthcare Association (IPHA) said comments made in an article in this newspaper last weekend “presented an unbalanced understanding of the role and benefits of new cancer drugs”.
Professor Michael Barry, who heads up the National Centre for Pharmacoeconomics (NCPE), had told The Sunday ...